Novartis India Share Price in 2019: Chart, Monthly Trends, & Analysis

How did Novartis India shares perform in 2019?

Let's find out!

Novartis India share price in 2019 was ₹667.6 Its price on 1st January 2019 was ₹721.05, and by 31st December 2019 it moved to ₹667.6, giving a negative return of -7.42% for the year.

Novartis India Share Open, High, Low, and Close prices for the Year 2019 are as follows:

Open	High	Low	Close
₹721.05	₹780	₹558	₹667.6
1st Jan 2019	Occured in Oct 2019	Occured in Aug 2019	31st Dec 2019

This page will help you understand how Novartis India performed in 2019. Let's get started.

For complete insights into Novartis India’s incredible stock price performance and growth, see: Novartis India Historical Share Price Data from its IPO to 2025

Table: Novartis India Share Monthly Close, Low, High Prices for 2019

Month	Novartis India	Change%	↑High - ↓Low
Jan	₹725.05	-	↑ ₹762.4 ↓ ₹702
Feb	₹693.25	-4.4%	↑ ₹734 ↓ ₹640.2
Mar	₹685.8	-1.1%	↑ ₹728.75 ↓ ₹675
Apr	₹691.6	0.8%	↑ ₹730 ↓ ₹680
May	₹694.4	0.4%	↑ ₹730 ↓ ₹661.2
Jun	₹664.75	-4.3%	↑ ₹697 ↓ ₹650
Jul	₹628.15	-5.6%	↑ ₹684.9 ↓ ₹625.1
Aug	₹567.65	-9.7%	↑ ₹647 ↓ ₹558
Sep	₹627.7	10.5%	↑ ₹675 ↓ ₹562.5
Oct	₹753.85	20%	↑ ₹780 ↓ ₹591.4
Nov	₹665.25	-11.8%	↑ ₹764 ↓ ₹640
Dec	₹667.6	0.3%	↑ ₹742.4 ↓ ₹661.05

Chart: CandleStick and Line Chart Showing Monthly Prices

[Click on line name to show/hide a line]

What if You invested ₹10,000 in Novartis India in 2019?

In 2019, the opening price of Novartis India share was ₹721.05. Today, the price stands at ₹672.25, reflecting a growth of -6.77%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2019 would have become ₹9,323.2 by 2025. This represents a CAGR of -1.16%.

---

You might also like to check: Novartis India Stock Price in 2018 or Novartis India Stock Price in 2020

---

References: Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.

Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.